INFORMAZIONI SU QUESTO ARTICOLO

Cita

1. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006; 91: 2906–2912.10.1210/jc.2006-059416735483 Search in Google Scholar

2. Chanson P, Salenave S. Metabolic Syndrome in Cushing’s Syndrome. Neuroendocrinology. 2010; 92(suppl 1): 96–101.10.1159/00031427220829627 Search in Google Scholar

3. Anagnostis P, Athyros VG, Tziomalos K, et al. Clinical Review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009 Aug; 94(8): 2692–701.10.1210/jc.2009-037019470627 Search in Google Scholar

4. Walker BR. Cortisol--cause and Cure for Metabolic Syndrome? Diabet Med. 2006 Dec; 23(12): 1281–8.10.1111/j.1464-5491.2006.01998.x17116176 Search in Google Scholar

5. Jessop DS, Dallman MF, Fleming D, at al. Resistance to Glucocorticoid Feedback in Obesity. J Clin Endocrinol Metab. 2001 Sep; 86(91): 4109–4114.10.1210/jcem.86.9.782611549634 Search in Google Scholar

6. Subeska Stratrova S, Dzikova S, Bogoev M, et al. Functional hypercorticism relations to the metabolic syndrome. BANTAO J. 2005; 3(2): 149–152. Search in Google Scholar

7. Kyle, Ursula GK, Laurence G, et al. Body composition: what’s new? Curr Opin Clin Nutr Metab Care. 2002 July; 5(4): 427–433. Search in Google Scholar

8. Geer EB, Shen W, Strohmayer E, et al. Body Composition and Cardiovascular Risk Markers after Remission of Cushing’s Disease: A Prospective Study Using Whole-Body MRI. J Clin Endocrinol Metab. 2012; 97:1702–1711.10.1210/jc.2011-3123333989022419708 Search in Google Scholar

9. Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab. 2007; 292: E654–E667.10.1152/ajpendo.00453.200617077342 Search in Google Scholar

10. Neeland IJ, Turer AT, Ayers CR, et al. Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol. 2015 May; 65(19): 2150–2151.10.1016/j.jacc.2015.01.061489046525975481 Search in Google Scholar

11. Shuster A, Patlas M, Pinthus JH et al. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012 Jan; 85(1009): 1–10.10.1259/bjr/38447238347392821937614 Search in Google Scholar

12. Borga M, West J, Bell JD, et al. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018 Jun; 66(5): 1–9.10.1136/jim-2018-000722599236629581385 Search in Google Scholar

13. Ulbrich EJ, Nanz D, Leinhard OD, et al. Whole-body adipose tissue and lean muscle volumes and their distribution across gender and age: MR - derived normative values in normal-weight Swiss population. Magn Reson Med. 2018 Jan; 79(1): 449-458.10.1002/mrm.26676 Search in Google Scholar

14. Kaul S, Rothney MP, Peters DM, et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring). 2012; 20(6): 1313–8.10.1038/oby.2011.393 Search in Google Scholar

15. Choi YJ, Seo YK, Lee EJ, et al. Quantification of visceral fat using dual-energy x-ray absorptiometry and its reliability according to the amount of visceral fat in Korean adults. J Clin Densitom. 2015 Apr-Jun; 18(2): 192–7.10.1016/j.jocd.2015.02.001 Search in Google Scholar

16. Shubeska Startrova S. Dual-energy x-ray absorptiometry assessment of the body composition in obese women. J Anthropol Soc Serbia (Novi Sad). 2009; 44: 455–461. Search in Google Scholar

17. Neeland IJ, Grundy SM, Li X, et al. Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study. Nutr Diabetes. 2016 Jul; 6(7): e221.10.1038/nutd.2016.28 Search in Google Scholar

18. Tiryakioglu O, Ugurlu S, Yalin S, et al. Screening for Cushing’s Syndrome in Obese Patients. Clinics (Sao Paulo). 2010 Jan; 65(1): 9–13.10.1590/S1807-59322010000100003 Search in Google Scholar

19. Ross EJ, Linch DC. Cushing’s syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet. 1982 Sep 18; 2(8299): 646–9.10.1016/S0140-6736(82)92749-0 Search in Google Scholar

20. Shubeska Stratrova S, Jovanovska Mishevska S, Bitoska I, et al. Diagnostic central obesity indexes cut-off point values determined with dual-energy X-ray absorptiometry in Cushing’s and obese women. Contributions. 2020; XLI (3): 19–27.10.2478/prilozi-2020-004133500372 Search in Google Scholar

21. Müller MJ, Geisler C. Defining obesity as a disease. Eur J Clin Nutr. 2017; 71: 1256–1258.10.1038/ejcn.2017.15528952604 Search in Google Scholar

22. Vallgarda S, Nielsen MEJ, Hansen AKK, et al. Should Europe follow the US and declare obesity a disease?: a discussion of the so-called utilitarian argument. Eur J Clin Nutr. 2017; 71: 1263–1267.10.1038/ejcn.2017.10328952605 Search in Google Scholar

23. Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017 Jul; 18(7): 715–723.10.1111/obr.1255128489290 Search in Google Scholar

24. Apovian CM. Obesity: Definition, Comorbidities, Causes, and Burden. Am J Manag Care. 2016 Jun; 22(7 Suppl): s176–85. Search in Google Scholar

25. Maggi S, Busetto L, Noale M et al. (2015). Obesity: Definition and epidemiology. In A. Lenzi, S. Migliaccio, & L. M. Donini (Eds.), Multidisciplinary approach to obesity: From assessment to treatment. Cham, Switzerland: Springer International Publishing, pp. 31–39.10.1007/978-3-319-09045-0_3 Search in Google Scholar

26. Sharma AM, Campbell-Scherer DL. Redefining obesity: beyond the numbers. Obesity (Silver Spring). 2017 Apr; 25(4): 660–661.10.1002/oby.2180128349662 Search in Google Scholar

27. Matsuzawa Y. Obesity and metabolic syndrome: the contribution of visceral fat and adiponectin. Diabetes Management. 2014; 4(4): 391–401.10.2217/dmt.14.30 Search in Google Scholar

28. Lesser IA, Dick TJ, Guenette JA, et al. The association between cardiorespiratory fitness and abdominal adiposity in postmenopausal, physically inactive South Asian women. Prev Med Rep. 2015 Sep; 2: 783–787.10.1016/j.pmedr.2015.09.007472141026844150 Search in Google Scholar

29. Neeland IJ, Turer AT, Ayers CR, et al. Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol. 2015; 65(19): 2150–2151.10.1016/j.jacc.2015.01.061489046525975481 Search in Google Scholar

30. Broom I. Thinking Around Abdominal Obesity and Cardiovascular Risk. Br J Diabetes Vasc Dis March. 2006; 6(2): 58–61.10.1177/14746514060060020301 Search in Google Scholar

31. Ladeiras-Lopes R, Sampaio F, Bettencourt N, et al. The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events. Rev Esp Cardiol (Engl Ed). 2017 May; 70(5): 331–337.10.1016/j.rec.2016.09.01027765543 Search in Google Scholar

32. Lopes HF, Correa-Giannella ML, Consolim-Colombo FM, et al. Viseral adiposity syndrome. Diabetol Metab Syndr. 2016; 8(40): B4–B12.10.1186/s13098-016-0156-2495071027437032 Search in Google Scholar

33. Ibrahim Q, Ahsan M. Measurement of Visceral Fat, Abdominal Circumference and Waist-hip Ratio to Predict Health Risk in Males and Females. Pakistan J Biol Sci. 2019; 22: 168–173.10.3923/pjbs.2019.168.17331930817 Search in Google Scholar

34. Rockall AG, Sohaib SA, Evans D, et al. Computed Tomography Assessment of Fat Distribution in Male and Female Patients With Cushing’s Syndrome. Eur J Endocrinol. 2003 Dec; 149(6): 561–7.10.1530/eje.0.149056114640998 Search in Google Scholar

35. Geer EB, Shen W, Gallagher D, et al. MRI assessment of lean and adipose tissue distribution in female patients with Cushing’s disease. Clin Endocrinol (Oxf). October 2010; 73(4): 469–475. Search in Google Scholar

36. Lee CM, Huxley RR, Wildman RP, et al. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008; 61: 646–653.10.1016/j.jclinepi.2007.08.012 Search in Google Scholar

37. Lönn L, Kvist H, Ernest I, et al. Changes in body composition and adipose tissue distribution after treatment of women with Cushing’s syndrome. Metabolism. December 1994, 43(12): 1517–1522.10.1016/0026-0495(94)90010-8 Search in Google Scholar

38. Kamel EG, McNeill G, Van Wijk MC, et al. Change in intra-abdominal adipose tissue volume during weight loss in obese men and women: correlation between magnetic resonance imaging and anthropometric measurements. Int J Obes Relat Metab Disord. 2000; 24: 607–613.10.1038/sj.ijo.080120410849583 Search in Google Scholar

39. Snijder MB, Visser M, Dekker JM, et al. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord. 2002 Jul; 26(7): 984–93.10.1038/sj.ijo.080196812080454 Search in Google Scholar

40. Brownbill RA, Ilich JZ. Measuring body composition in overweight individuals by dual energy x-ray absorptiometry. BMC Med Imaging. 2005; 5: 1.10.1186/1471-2342-5-1107984715748279 Search in Google Scholar

41. Denton N, Karpe F. Measuring body composition and regional fat mass accurately. Practical diabetes. 2016; 33(7): 224-226.10.1002/pdi.2043 Search in Google Scholar

42. Jensen MD, Kanaley JA, Reed JE, Sheedy PF. Measurement of abdominal and visceral fat with computed tomography and dual-energy X-ray absorptiometry. Am J Clin Nutr. 1995; 61: 274–278.10.1093/ajcn/61.2.2747840063 Search in Google Scholar

43. Laddu DR, Lee VR, Blew RM, et al. Predicting visceral adipose tissue by MRI using DXA and anthropometry in adolescents and young adults. Int J Body Compos Res. 2012; 10(4): 93–100. Search in Google Scholar

44. Kullberg J, Brandberg J, Angelhed JE, et al. Whole-body adipose tissue analysis: comparison of MRI, CT and dual energy X-ray absorptiometry. Br J Radiol. 2009 Feb; 82(974): 123–30.10.1259/bjr/8008315619168691 Search in Google Scholar

45. Kim JS, Yoo SM, Kim KN, Lee SY. Comparison of DXA and CT for truncal obesity in adult women related to metabolic complications. J Korean Acad Fam Med. 2007 Sep; 28(9): 675–681. Search in Google Scholar

46. Wajchenberg BL, Bosco A, Marone MM, et al. Estimation of body fat and lean tissue distribution by dual energy x-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing’s disease. J Clin Endocrinol Metab. 1995; 80(9): 2791–2794. Search in Google Scholar

47. Jebb SA. Measurement of soft tissue composition by dual X-ray absorptiometry. Br J Nutr. 1997; 77(2): 151–163.10.1079/BJN199700219135364 Search in Google Scholar

48. Burt MG, Gibney J, Ho KKY. Characterization of the metabolic phenotypes of Cushing’s syndrome and growth hormone deficiency: a study of body composition and energy metabolism. Clin Endocrinol (Oxf). 2006 Apr; 64(4): 436–443.10.1111/j.1365-2265.2006.02488.x16584517 Search in Google Scholar

49. Mayo-Smith W, Hayes CW, Biller BM, et al. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology. 1989 Feb; 170(2): 515–8.10.1148/radiology.170.2.29116782911678 Search in Google Scholar

50. Schafroth UK, Godang K, Ueland T, et al. Leptin levels in relation to body composition and insulin concentration in patients with endogenous Cushing’s syndrome compared to controls matched for body mass index. J Endocrinol Invest. 2000; 23(6): 349–355.10.1007/BF0334373710908161 Search in Google Scholar

51. Garrapa GG, Pantanetti P, Arnaldi G, et al. Body composition and metabolic features in women with adrenal incidentaloma or Cushing’s Syndrome. J Clin Endocrinol Metab. 2001; 86(11): 5301–5306. Search in Google Scholar

52. Salamone LM, Fuerst T, Visser M. Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol. 2000; 89(1): 345–52.10.1152/jappl.2000.89.1.34510904070 Search in Google Scholar

53. Hunter HL, Nagy TR. Body composition in a seasonal model of obesity: longitudinal measures and validation of DXA. Obes Res. 2002 Nov; 10(11): 1180–1187.10.1038/oby.2002.16012429883 Search in Google Scholar

eISSN:
1857-8985
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicina, Scienze medicali di base, Storia ed etica della medicina, Medicina clinica, altro, Scienze sociali, Educazione